Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Howlett

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
CMAJ Open|October 13, 2016
The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysisDat T Tran, Arto Ohinmaa, Nguyen X Thanh, et al.
The Canadian Journal of Cardiology|November 8, 2017
The Need for Heart Failure Advocacy in CanadaSean A Virani, Marc Bains, Jillianne Code, et al.
The Canadian Journal of Cardiology|May 30, 2015
Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysisRobert J H Miller, Jonathan G Howlett, Derek V Exner, et al.
Open Heart|February 10, 2026
Factors associated with the development of severe mitral regurgitation in patients with heart failureFiras Ahmed, Erik Youngson, Anusha Sasikumar, et al.
The Canadian Journal of Cardiology|June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying MechanismsG B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
European Journal of Heart Failure|January 16, 2023
Cost-effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failureRobert J H Miller, Derek S Chew, Lei Qin, et al.
The Canadian Journal of Cardiology|September 12, 2009
Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registryJonathan G Howlett, O Elizabeth Mann, Robert Baillie, et al.
International Journal of Cardiology. Heart & Vasculature|March 30, 2026
Machine learning model for predicting improvement in left ventricular systolic function in patients with heart failure and reduced ejection fractionNariman Sepehrvand, Caitlyn Gilbert, Alec Chunta, et al.
The Canadian Journal of Cardiology|August 25, 2024
Factors Influencing Clinical Initiation of Tafamidis Therapy for Transthyretin Amyloidosis Cardiomyopathy: A Canadian Referral Center ExperienceKaran Shahi, Robert J H Miller, Steven Dykstra, et al.
Journal of Clinical Medicine|September 28, 2024
Baseline Predictors of Adverse Outcomes for Transthyretin Amyloidosis Cardiomyopathy Patients Treated and Untreated with Tafamidis: A Canadian Referral Center ExperienceKaran Shahi, Robert J H Miller, Steven Dykstra, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
CMAJ Open|October 13, 2016
The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysisDat T Tran, Arto Ohinmaa, Nguyen X Thanh, et al.
The Canadian Journal of Cardiology|November 8, 2017
The Need for Heart Failure Advocacy in CanadaSean A Virani, Marc Bains, Jillianne Code, et al.
The Canadian Journal of Cardiology|May 30, 2015
Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysisRobert J H Miller, Jonathan G Howlett, Derek V Exner, et al.
Open Heart|February 10, 2026
Factors associated with the development of severe mitral regurgitation in patients with heart failureFiras Ahmed, Erik Youngson, Anusha Sasikumar, et al.
The Canadian Journal of Cardiology|June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying MechanismsG B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
European Journal of Heart Failure|January 16, 2023
Cost-effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failureRobert J H Miller, Derek S Chew, Lei Qin, et al.
The Canadian Journal of Cardiology|September 12, 2009
Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registryJonathan G Howlett, O Elizabeth Mann, Robert Baillie, et al.
International Journal of Cardiology. Heart & Vasculature|March 30, 2026
Machine learning model for predicting improvement in left ventricular systolic function in patients with heart failure and reduced ejection fractionNariman Sepehrvand, Caitlyn Gilbert, Alec Chunta, et al.
The Canadian Journal of Cardiology|August 25, 2024
Factors Influencing Clinical Initiation of Tafamidis Therapy for Transthyretin Amyloidosis Cardiomyopathy: A Canadian Referral Center ExperienceKaran Shahi, Robert J H Miller, Steven Dykstra, et al.
Journal of Clinical Medicine|September 28, 2024
Baseline Predictors of Adverse Outcomes for Transthyretin Amyloidosis Cardiomyopathy Patients Treated and Untreated with Tafamidis: A Canadian Referral Center ExperienceKaran Shahi, Robert J H Miller, Steven Dykstra, et al.
Pageof 13